Axons, nerve cell projections that carry electrical signals from one cell to another, may look more like pearls on a…
Andrea Lobo
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo
Supervised exercises at home may safely improve motor function and quality of life in people with mild to moderate…
A clinical trial testing the safety and tolerability of Brenig Therapeutics‘ BT-267, a potential disease-modifying therapy for Parkinson’s due…
Ochsner Health, a healthcare provider in the U.S. Gulf South, has been named one of six new study sites…
Angels on Call, a home care services provider, has been granted Certified Parkinson Disease Care (CPDC) accreditation by the…
CND Life Sciences has been awarded a $4.2 million grant from The Michael J. Fox Foundation for Parkinson’s…
For a 69-year-old man with advanced Parkinson’s disease, sleeping with the head of his bed elevated helped to decrease…
A Phase 3 clinical trial evaluating investigational oral therapy solengepras as a treatment for Parkinson’s disease has dosed…
Vivolta and Neurochase have partnered to manufacture specialized micro-catheters using the former’s medical electrospinning (MediSpin) technology to…
ACI-7104, an investigational vaccine to treat people in the early stages of Parkinson’s disease, is showing safety and…